|
WHSC1L1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.831000E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.03560000000747E-05 |
| Normal-vs-Stage2 |
3.037600E-03 |
| Normal-vs-Stage3 |
1.096140E-02 |
| Normal-vs-Stage4 |
3.084100E-02 |
| Stage1-vs-Stage2 |
9.583800E-01 |
| Stage1-vs-Stage3 |
5.229200E-01 |
| Stage1-vs-Stage4 |
5.236400E-01 |
| Stage2-vs-Stage3 |
5.642600E-01 |
| Stage2-vs-Stage4 |
5.853600E-01 |
| Stage3-vs-Stage4 |
3.091400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.201200E-03 |
| Normal-vs-AfricanAmerican |
5.833500E-04 |
| Normal-vs-Asian |
8.150000E-04 |
| Caucasian-vs-AfricanAmerican |
6.156400E-01 |
| Caucasian-vs-Asian |
7.217800E-02 |
| AfricanAmerican-vs-Asian |
2.453200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.449760E-04 |
| Normal-vs-Female |
1.787810E-01 |
| Male-vs-Female |
2.485500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.360700E-03 |
| Normal-vs-Extreme_Weight |
4.8824999999697E-06 |
| Normal-vs-Obese |
1.515730E-02 |
| Normal-vs-Extreme_Obese |
9.92069999999901E-05 |
| Normal_Weight-vs-Extreme_Weight |
5.752800E-01 |
| Normal_Weight-vs-Obese |
2.639800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.443200E-01 |
| Extreme_Weight-vs-Obese |
4.807600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.417200E-01 |
| Obese-vs-Extreme_Obese |
5.648000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.547000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.740800E-03 |
| Normal-vs-Age(61-80Yrs) |
1.439910E-03 |
| Normal-vs-Age(81-100Yrs) |
3.82480000005181E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.457600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.195200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.208000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.467600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.548250E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.464100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.257300E-03 |
| Normal-VS-Type2 PRCC |
4.42549999979391E-07 |
| Normal-VS-KIRP CIMP |
8.391000E-01 |
| Normal-VS-Unclassified PRCC |
7.130300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.329700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.844400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.513000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.823700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.636200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.392000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.3972000464172E-09 |
| Normal-vs-N1 |
5.933800E-01 |
| Normal-vs-N2 |
5.956600E-01 |
| N0-vs-N1 |
9.955900E-02 |
| N0-vs-N2 |
3.174300E-02 |
| N1-vs-N2 |
4.847800E-01 |
|
|
